Stock Analysis

VPower Group International Holdings And 2 More Prominent Asian Penny Stocks

As global markets navigate the complexities of economic shifts, Asia's financial landscape continues to capture attention with its unique dynamics and potential opportunities. Penny stocks, often considered a relic from past market eras, remain relevant as they offer an intriguing mix of affordability and growth potential. For investors looking beyond mainstream options, these smaller or newer companies can present compelling opportunities when backed by strong financials and solid fundamentals.

Advertisement

Top 10 Penny Stocks In Asia

NameShare PriceMarket CapRewards & Risks
JBM (Healthcare) (SEHK:2161)HK$2.71HK$2.21B✅ 3 ⚠️ 1 View Analysis >
Lever Style (SEHK:1346)HK$1.48HK$915.41M✅ 4 ⚠️ 1 View Analysis >
TK Group (Holdings) (SEHK:2283)HK$2.56HK$2.12B✅ 4 ⚠️ 1 View Analysis >
Perfect Medical Health Management (SEHK:1830)HK$1.41HK$1.77B✅ 2 ⚠️ 1 View Analysis >
CNMC Goldmine Holdings (Catalist:5TP)SGD1.00SGD405.29M✅ 4 ⚠️ 1 View Analysis >
Atlantic Navigation Holdings (Singapore) (Catalist:5UL)SGD0.103SGD53.92M✅ 2 ⚠️ 4 View Analysis >
Yangzijiang Shipbuilding (Holdings) (SGX:BS6)SGD3.37SGD13.26B✅ 5 ⚠️ 1 View Analysis >
F & J Prince Holdings (PSE:FJP)₱2.20₱841.12M✅ 2 ⚠️ 3 View Analysis >
Livestock Improvement (NZSE:LIC)NZ$1.00NZ$142.34M✅ 2 ⚠️ 5 View Analysis >
Scott Technology (NZSE:SCT)NZ$3.02NZ$258.17M✅ 4 ⚠️ 1 View Analysis >

Click here to see the full list of 959 stocks from our Asian Penny Stocks screener.

Let's dive into some prime choices out of the screener.

VPower Group International Holdings (SEHK:1608)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: VPower Group International Holdings Limited is an investment holding company that designs, integrates, sells, and installs engine-based electricity generation units across Hong Kong, Mainland China, other Asian countries, Latin America, and internationally with a market cap of approximately HK$1.22 billion.

Operations: The company generates revenue through its System Integration segment, contributing HK$470.96 million, and its Investment, Building and Operating segment, which accounts for HK$907.96 million.

Market Cap: HK$1.22B

VPower Group International Holdings, with a market cap of HK$1.22 billion, operates in the engine-based electricity generation sector and is currently unprofitable. Despite generating revenue through its System Integration (HK$470.96 million) and Investment segments (HK$907.96 million), the company faces challenges such as high net debt to equity ratio at 97.6% and increasing losses over the past five years by 54.4% annually. However, it has a strong cash position with short-term assets exceeding liabilities and a cash runway extending beyond three years if current free cash flow levels are maintained, providing some financial stability amidst volatility.

SEHK:1608 Debt to Equity History and Analysis as at Dec 2025
SEHK:1608 Debt to Equity History and Analysis as at Dec 2025

Jinhai Medical Technology (SEHK:2225)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Jinhai Medical Technology Limited is an investment holding company that offers minimally invasive surgery solutions, medical products, and related services in the People's Republic of China and Singapore, with a market cap of HK$6.56 billion.

Operations: The company's revenue is derived from two primary regions, with SGD 14.82 million generated in Singapore and SGD 19.83 million from the People's Republic of China.

Market Cap: HK$6.56B

Jinhai Medical Technology, with a market cap of HK$6.56 billion, operates in the medical sector across China and Singapore. Despite generating revenue of SGD 34.65 million from these regions, the company remains unprofitable with increasing losses over five years at a rate of 83.8% annually. Short-term assets (SGD 23.7 million) exceed both short-term and long-term liabilities, providing some liquidity cushion despite a volatile share price and high weekly volatility compared to most Hong Kong stocks. Recent capital raising extends its cash runway beyond six months, while experienced management offers potential stability amid financial challenges and strategic changes within the company.

SEHK:2225 Financial Position Analysis as at Dec 2025
SEHK:2225 Financial Position Analysis as at Dec 2025

AIRA Capital (SET:AIRA)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: AIRA Capital Public Company Limited, with a market cap of THB6.82 billion, operates in Thailand through its subsidiaries by providing investment and financial advisory services.

Operations: AIRA Capital's revenue is primarily derived from its Property Development segment at THB290 million, followed by Securities and Investment Business at THB288 million, Factoring at THB134 million, Rental and Service Business (Excluding Property Development) at THB76 million, and Advisory and Investment Banking contributing THB9 million.

Market Cap: THB6.82B

AIRA Capital, with a market cap of THB6.82 billion, derives significant revenue from its Property Development and Securities segments but remains unprofitable. Despite this, the company has a positive cash flow and sufficient runway for over three years if current conditions persist. A seasoned board and management team contribute to strategic stability, although high net debt to equity (86.1%) presents financial challenges. Recent earnings reports indicate declining revenues and marginally reduced net losses compared to the previous year. Share price volatility remains high relative to other Thai stocks, reflecting market uncertainty amid ongoing financial restructuring efforts.

SET:AIRA Debt to Equity History and Analysis as at Dec 2025
SET:AIRA Debt to Equity History and Analysis as at Dec 2025

Next Steps

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About SEHK:2225

Jinhai Medical Technology

An investment holding company, provides minimally invasive surgery solutions, medical products, and related services in the People's Republic of China and Singapore.

Excellent balance sheet with very low risk.

Advertisement

Weekly Picks

RO
RockeTeller
SCZ logo
RockeTeller on Santacruz Silver Mining ·

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

Fair Value:CA$8696.7% undervalued
75 users have followed this narrative
7 users have commented on this narrative
21 users have liked this narrative
RO
Robbo
FID logo
Robbo on Fiducian Group ·

Fiducian: Compliance Clouds or Value Opportunity?

Fair Value:AU$121.2% undervalued
13 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative
WO
WVVI logo
woodworthfund on Willamette Valley Vineyards ·

Willamette Valley Vineyards (WVVI): Not-So-Great Value

Fair Value:US$245.0% overvalued
11 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative

Updated Narratives

NO
S5L logo
Norms70 on Standard Lithium ·

SLI is share to watch next 5 years

Fair Value:€4.57.6% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DA
davidlsander
BEAM logo
davidlsander on Beam Therapeutics ·

The "Molecular Pencil": Why Beam's Technology is Built to Win

Fair Value:US$15081.9% undervalued
61 users have followed this narrative
3 users have commented on this narrative
0 users have liked this narrative
RE
PRME logo
RedhawkCC on Prime Medicine ·

PRME remains a long shot but publication in the New England Journal of Medicine helps.

Fair Value:US$0.0469.1k% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TH
TheWallstreetKing
MVIS logo
TheWallstreetKing on MicroVision ·

MicroVision will explode future revenue by 380.37% with a vision towards success

Fair Value:US$6098.5% undervalued
118 users have followed this narrative
11 users have commented on this narrative
22 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$250.3925.9% undervalued
962 users have followed this narrative
6 users have commented on this narrative
25 users have liked this narrative
RO
RockeTeller
SCZ logo
RockeTeller on Santacruz Silver Mining ·

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

Fair Value:CA$8696.7% undervalued
75 users have followed this narrative
7 users have commented on this narrative
21 users have liked this narrative